Computer-Assisted Therapy for Depression

  • STATUS
    Recruiting
  • participants needed
    100
Send
Updated on 19 February 2024

Summary

The purpose of this study is to learn more about the treatment success of Computer-augmented Cognitive Behavioral Therapy (CCBT) and examine the neural connections of patients with depression via functional Magnetic Resonance Imaging (fMRI) scans.

Computer-augmented Cognitive Behavioral Therapy (CCBT) is approved by the FDA as a form of treatment for depression. CCBT is done partly on the computer, and partly with a therapist.  The program relies on the same concepts as normal Cognitive Behavioral Therapy (CBT) and may help you change the way you think about and approach different situations. Previous research studies have demonstrated that the CCBT treatment offered through this study is comparable to standard CBT in treating depression.

Participation last 8-12 weeks. All participants with depression will complete 1-3 fMRI scans, CCBT treatment, clinical interviews, and self-reported questionnaires. This study provides compensation participants for their time. 

Description

All eligible participants will be asked to complete the following: 

1) Clinical interview and self-report questionnaires
2) fMRI scans
3) At-home activity and mood monitoring. 

Participants with depression will receive CCBT and be randomly assigned to one of two study groups: 
1) Early CCBT –  begin CCBT within 0-14 days from Visit #1 and after the completion of the first fMRI scan. Participation in the Early CCBT group lasts approximately 8 weeks.

2) Late CCBT –  start CCBT within 15-28 days from Visit #1 and after completing two fMRI scans - these fMRI scans must be at least 14 days apart from each other. Participation in the Late CCBT group lasts 12 weeks.

Participants without depression will not receive CCBT and participate in 3 study visits over approximately 8 weeks. 

FAQ


Details
Condition Affective Symptoms,Depression,Chemical Depression,Major depression,Depression,Postpartum depression,Dysthymia,Mood Disorders,Therapy,MajorDepressiveDisorder,depression,depression.
Age 18years - 60years
Clinical Study IdentifierTX4816
Last Modified on19 February 2024

Eligibility

How to participate?

Step 1 Connect with a study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.